Document Detail


Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
MedLine Citation:
PMID:  23314103     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Drugs that inhibit DNA topoisomerase I and DNA topoisomerase II have been widely used in cancer chemotherapy. We report herein the results of a focused medicinal chemistry effort around novel ellipticinium salts which target topoisomerase I and II enzymes with improved solubility. The salts were prepared by reaction of ellipticine with the required alkyl halide and evaluated for DNA intercalation, topoisomerase inhibition and growth inhibition against 12 cancer cell lines. Results from the topoisomerase I relaxation assay indicated that all novel ellipticine derivatives behaved as intercalating agents. At a concentration of 100 μM, specific topoisomerase I inhibition was not observed. Two of the derivatives under investigation were found to fully inhibit the DNA decatenation reaction at a concentration of 100 μM, indicative of topoisomerase II inhibition. N-Alkylation of ellipticine was found to enhance the observed growth inhibition across all cell lines and induce growth inhibition comparable to that of Irinotecan (CPT-11; GI(50) 1-18 μM) and in some cell lines better than Etoposide (VP-16; GI(50) = 0.04-5.2 μM). 6-Methylellipticine was the most potent growth inhibitory compound assessed (GI(50) = 0.47-0.9 μM). N-Alkylation of 6-methylellipticine was found to reduce this response with GI(50) values in the range of 1.3-28 μM.
Authors:
Fiona M Deane; Elaine C O'Sullivan; Anita R Maguire; Jayne Gilbert; Jennette A Sakoff; Adam McCluskey; Florence O McCarthy
Related Documents :
15107923 - Dna extraction and quantification from touch and scrape preparations obtained from auto...
21474753 - Ribozyme-catalyzed transcription of an active ribozyme.
22284513 - Heterogeneous electrochemiluminescence spectrometry of ru(bpy)(3)(2+) for determination...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-14
Journal Detail:
Title:  Organic & biomolecular chemistry     Volume:  -     ISSN:  1477-0539     ISO Abbreviation:  Org. Biomol. Chem.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101154995     Medline TA:  Org Biomol Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Chemistry and Analytical and Biological Chemistry Research Facility, University College Cork, Cork, Ireland. f.mccarthy@ucc.ie.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Synthesis, bioassay, crystal structure and ab initio studies of Erlenmeyer azlactones.
Next Document:  Singular phase nano-optics in plasmonic metamaterials for label-free single-molecule detection.